Ritanserin in Treatment of Cocaine Dependence - 1

Completed · Phase 2

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.

Key facts

Study ID

NCT00000187

Run by

University of Pennsylvania

People needed

80

Starts

1992-07-01

Last updated by the study team

2015-05-28

Who can join

Age: 28 and older, up to 47. Sex: male. Healthy volunteers: not accepted.

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.